摘要
简要介绍已广泛用于临床的32P,89Sr,90Y,103Pd,125I,131I,137Cs,153Sm,186Re,188Re,192Ir和具有很大潜在使用可能性的64Cu,67Cu,67Ga,86Y,105Rh,111In,114mIn,124I,149Pm,166Ho,169Yb,177Lu,211At,213Bi,225Ac 26个放射性核素利用反应堆或加速器或衰变的55种不同途径产生的核数据的测量、理论计算及数据可靠性的初步评价,以改善其在诊断和治疗医用中的安全性、有效性和科学性。
The nuclear data measurements and preliminary evaluation as well as calculation for established and emerging 26 radionuclides produced in 55 ways by using reactor or accelerator or decay are briefly introduced in order to keep the safety and validity in medical therapeutic applications. The 11 established radionuclides are ^32P,^89Sr,^90Y,^103Pd,^125I,^131I,^137Cs,^153Sm,^186Re,^188Re,^192Ir and the 15 emerging radionuclides are 64Cu,^67Cu,^67Ga,^86Y,^105Rh,^111In,^114mIn,^124I,^149Pm,^166Ho,^169Yb,^177Lu,^211At,^213Bi,^225Ac.
出处
《原子核物理评论》
CAS
CSCD
北大核心
2006年第1期78-83,共6页
Nuclear Physics Review
关键词
医用同位素
核数据
测量
评价
therapeutic radionuclide production
nuclear data
evaluation